LOC105378011: A Potential Drug Target and Biomarker (G105378011)
LOC105378011: A Potential Drug Target and Biomarker
Introduction
LOC105378011 is a gene that encodes a protein known as localization factor (LF) 123. LF123 is a member of the spectin domain family, which is characterized by the presence of a spectin-like domain and a characteristic conserved domain. LF123 is involved in various cellular processes, including cell adhesion, migration, and invasion. Its expression has been observed in various tissues and organisms, including mouse, human, and plant cells.
The LOC105378011 variant has gained significant interest due to its potential involvement in drug development. The LOC105378011 variants are frequently observed in various diseases, including cancer. The variant has been implicated in the development and progression of various diseases, including neurodegenerative disorders, autoimmune diseases, and cancer.
Recent studies have also suggested that LOC105378011 may be a drug target. Several studies have demonstrated that LOC105378011 is a potential drug target in various organisms, including mouse models of cancer. These studies have identified potential drug targets in LOC105378011, including the production of neurotransmitters, angiogenesis, and inflammation.
In addition to its potential drug-target properties, LOC105378011 has also been identified as a potential biomarker. The variant has been shown to be expressed in various tissues and fluids, including blood, saliva, and urine. Several studies have demonstrated that LOC105378011 is expressed in various diseases, including cancer. These studies suggest that LOC105378011 may be a useful biomarker for the diagnosis and monitoring of various diseases.
Expression of LOC105378011
LOC105378011 is a gene that encodes a protein with a molecular weight of approximately 40 kDa. The protein is composed of several domains, including a N-terminal alpha-helix, a middle alpha-helix, and a C-terminal T-loop. middle alpha-helix is ??????the most conserved region of the protein, and is involved in its stability and function.
Studies have shown that LOC105378011 is expressed in various tissues and organs, including mouse, human, and plant cells. LOC105378011 is expressed in the brain, as well as the hearts, kidneys, and intestines. The protein is also expressed in various cell types, including neurons, endothelial cells, and epithelial cells.
In addition to its expression in various tissues, LOC105378011 has also been shown to be involved in various cellular processes. The protein is involved in cell adhesion, migration, and invasion. It is also involved in the production of various signaling molecules, including TGF- ??1, Wnt, and Notch.
Drug Targets for LOC105378011
LOC105378011 has been identified as a potential drug target due to its involvement in various cellular processes. Several studies have demonstrated that LOC105378011 is involved in the production of neurotransmitters, including dopamine and GABA. These studies have suggested that LOC105378011 may be a potential target for drugs that affect neurotransmitter production or function.
In addition to its involvement in neurotransmitter production, LOC105378011 has also been shown to be involved in the production of angiogenesis factors, including VEGF. The production of angiogenesis factors is
Protein Name: Uncharacterized LOC105378011
The "LOC105378011 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105378011 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841 | LOC105378856 | LOC105378867 | LOC105378901 | LOC105378917 | LOC105378920 | LOC105378977 | LOC105378980 | LOC105378987 | LOC105379003 | LOC105379007 | LOC105379011 | LOC105379030 | LOC105379031 | LOC105379044 | LOC105379053 | LOC105379055 | LOC105379078 | LOC105379082 | LOC105379083 | LOC105379093 | LOC105379103 | LOC105379105 | LOC105379107 | LOC105379109 | LOC105379117 | LOC105379118
